| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/16/2005 | US20050131215 Nucleotide sequences coding ribosomal polypeptides for use as tool in detection of modulator for treatment of bacterial infection; bactericides; microbiocides |
| 06/16/2005 | US20050131212 Neurogenic peptide for use in enhancement of neuronal migration, proliferation, survival, differentiation, and/or neurite outgrowth |
| 06/16/2005 | US20050130931 Compositions for the treatment of glaucoma or ocular hypertension |
| 06/16/2005 | US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction |
| 06/16/2005 | US20050130919 Allow for inhibition of the expression of target alleles in a spatially and temporally regulatable manner; useful for investigating gene functions; genetic engineering |
| 06/16/2005 | US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130213 Selective ligation and amplification assay |
| 06/16/2005 | US20050130208 Displacement assay for detection of small molecules |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130199 Mutations in WNT-frizzled signaling pathways associated with osteoarthritis |
| 06/16/2005 | US20050130195 Functional molecule and process for producing the same |
| 06/16/2005 | US20050130191 forming multibranched polyamide amine dendrimer molecules on walls of a U-shaped flow channel through which a solution containing target DNA is flowed;binding probe DNA to tips of said multibranched polyamide amine dendrimer molecules; andextracting said target DNA by hybridization with probes |
| 06/16/2005 | US20050130190 Mutations in ion channel proteins associated with sudden cardiac death |
| 06/16/2005 | US20050130184 Expression vector comprising coded looped RNA sequences for use in the prevention and treatment nervous system disorders; RNA interference |
| 06/16/2005 | US20050130181 RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA) |
| 06/16/2005 | US20050130180 Making a three-dimensional nucleic acid structure formed with a trimer by mixing at least three complementary polynucleotides in solution; each polynucleotide has a non-complementary sticky end; genetic engineering; high yield, purity |
| 06/16/2005 | US20050130173 Methods of amplifying and sequencing nucleic acids |
| 06/16/2005 | US20050130171 Complementary DNA library comprising nucleotide sequences expressed in brain for use as tool in diagnosis, prevention and treatment of cerebral and cognitive functioning disorders |
| 06/16/2005 | US20050130156 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 06/16/2005 | US20050130155 Primers for the detection and identification of bacterial indicator groups and virulene factors |
| 06/16/2005 | US20050130154 Compositions and methods relating to endometrial specific genes and proteins |
| 06/16/2005 | US20050130151 Fragile X mental retardation protein (FMRP) binding site for use as tool in detection, treatment and prevention of cognitive and motor disorders |
| 06/16/2005 | US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 06/16/2005 | US20050130133 Oligonucleotide primers derived from west nile viral consensus sequence for use in classification, identification and diagnosis of viral infection; blood screening |
| 06/16/2005 | US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design |
| 06/16/2005 | US20050129705 hepatitis C virus; for activating cytotoxic t lymphocytes in presence of major histomcompatibility complex |
| 06/16/2005 | US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines |
| 06/16/2005 | US20050129672 For isolating an enriched or purified population of motor neurons from a mixed population of human brain and/or spinal cells; for therapeutically targeting motor neurons eg myeloradiculopathy |
| 06/16/2005 | CA2549913A1 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression |
| 06/16/2005 | CA2546452A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/15/2005 | EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 06/15/2005 | EP1541678A1 Nucleic acid analysis chip and nucleic acid analyzer |
| 06/15/2005 | EP1540011A2 Method of detecting and quantifying hepatitis c virus |
| 06/15/2005 | EP1540010A2 Use of biomarkers for detecting ovarian cancer |
| 06/15/2005 | EP1540008A2 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 06/15/2005 | EP1540007A2 Nucleic acid labeling methods |
| 06/15/2005 | EP1540006A2 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
| 06/15/2005 | EP1540004A2 Double stranded rna structures and constructs, and methods for generating and using the same |
| 06/15/2005 | EP1540003A2 Methods and composition for detecting targets |
| 06/15/2005 | EP1540001A1 Nucleic-acid ink compositions for arraying onto a solid support |
| 06/15/2005 | EP1539980A2 Multi-step synthesis of templated molecules |
| 06/15/2005 | EP1539952A1 Method for the expression of unknown environmental dna into adapted host cells |
| 06/15/2005 | EP1539944A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 06/15/2005 | EP1539943A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 06/15/2005 | EP1539938A1 Chimeric gb virus b (gbv-b) |
| 06/15/2005 | EP1539807A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/15/2005 | EP1539801A2 Synthetic heparin-binding growth factor analogs |
| 06/15/2005 | EP1539791A2 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 06/15/2005 | EP1539790A2 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 06/15/2005 | EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 06/15/2005 | EP1539784A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
| 06/15/2005 | EP1539778A2 Deprotection and purification of oligonucleotides and their derivatives |
| 06/15/2005 | EP1539689A2 Antisense modulation of endothelial lipase expression |
| 06/15/2005 | EP1539237A2 Humanized antibodies against human 4-1bb |
| 06/15/2005 | EP1539228A2 Novel composition and methods for the treatment of immune related diseases |
| 06/15/2005 | EP1539189A2 Method of using anti-apoptotic factors in gene expression |
| 06/15/2005 | EP1538904A2 Immunostimulatory nucleic acids |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628127A Genes from drought stress tolerant tea plant and method of introducing water-stress tolerance |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1628124A Heteroconfigurational polynucleotide and methods of use |
| 06/15/2005 | CN1628123A Methods for separating oligonucleotides |
| 06/15/2005 | CN1626661A Phytohemagglutinin and application |
| 06/15/2005 | CN1626660A Promoter for regulating and controlling lignin to synthesize relevant enzyme gene and application |
| 06/15/2005 | CN1626544A Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacterin |
| 06/15/2005 | CN1206367C Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use |
| 06/15/2005 | CN1206366C Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use |
| 06/15/2005 | CN1206354C Plant gene promotor for quickly inducing defect stimulation and high efficienly expression |
| 06/14/2005 | US6906185 Derivatives of 7-deaza -2′-deoxyguanosine-5'-triphosphate, preparation and use thereof |
| 06/14/2005 | US6905868 Cleaning compounds; animal feeds |
| 06/14/2005 | US6905848 Comprises oligonucleotide sequences for detection of proteolytic enzymes associated with opening beta-lactam rings of penicillins and cephalosporins in genomes of gram negative bacteria |
| 06/14/2005 | US6905845 Isolated nucleic acids; allergies sensitivity |
| 06/14/2005 | US6905842 Modulation signal transduction; isolated nucleic acids; genetic engineering |
| 06/14/2005 | US6905837 Detection open reading frames fo Dna sequences; calibration |
| 06/14/2005 | US6905825 Isolation and purification of nucleotide sequences; obtain sample, adsorb to support, wash with buffer, recover nucleotide sequences |
| 06/14/2005 | US6905817 Screening signal antagonist; glial cell neutrotropic factor; therapy for nervous system disorders |
| 06/14/2005 | US6905683 Prevents side effects such as systemic activation of coagulation system, bleeding |
| 06/09/2005 | WO2005052590A1 High-throughput screening method for integrin antagonist and new peptide screened therefrom |
| 06/09/2005 | WO2005052191A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | WO2005052170A2 Gene silencing by using micro-rna molecules |
| 06/09/2005 | WO2005052148A2 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
| 06/09/2005 | WO2005052127A2 Real-time detection of nucleic acids and proteins |
| 06/09/2005 | WO2005052123A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof |
| 06/09/2005 | WO2005051994A2 Ztnf11, a tumor necrosis factor |
| 06/09/2005 | WO2005051993A1 Novel muscle growth regulator |
| 06/09/2005 | WO2005051977A2 Conditional allele system |
| 06/09/2005 | WO2005051967A2 Oligonucleotides labeled with a plurality of fluorophores |
| 06/09/2005 | WO2005033340A3 Methods and kits for hybridizing multiple probe panels to nucleic acid samples |
| 06/09/2005 | WO2005031003A9 Mutations in wnt-frizzled signaling pathways associated with osteoarthritis |
| 06/09/2005 | WO2005030787A3 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/09/2005 | WO2005024386A3 Use of photopolymerization for amplification and detection of a molecular recognition event |
| 06/09/2005 | WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 06/09/2005 | WO2005021592A3 Enhancing the circulating half-life of interleukin-2 proteins |
| 06/09/2005 | WO2005021563A3 Method and materials for bisulfite conversion of cytosine to uracil |
| 06/09/2005 | WO2005017153A3 Methods for synthesis of defined polynucleotides |
| 06/09/2005 | WO2005017113A3 Metalloproteinase gene polymorphism in copd |
| 06/09/2005 | WO2005014812A3 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 06/09/2005 | WO2005010142A3 Plant centromere compositions |